CKAP2 is up-regulated in a variety of malignant tumors and has diagnostic value in osteosarcoma (44), triple-negative breast cancer (45), gastric cancer, and other tumors (46). This evidence concerns the gene CKAP2 and triple-negative breast carcinoma.